Erratum: 12/15-Lipoxygenase-dependent ROS production is required for diet-induced endothelial barrier dysfunction (Journal of Lipid Research (2015) 56 (562–577) DOI: 10.1194/jlr.M055566);12/15-Lipoxygenase-dependent ROS production is required for diet-induced endothelial barrier dysfunction

Journal of Lipid Research

Volumn 56, Issue 3, 2015, Pages 562-577

  Chattopadhyay, Rima ^a   Tinnikov, Alexander ^a   Dyukova, Elena ^a   Singh, Nikhlesh K ^a   Kotla, Sivareddy ^a   Mobley, James A ^b   Rao, Gadiparthi N ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b Kentucky   (United States)

Author keywords

15(s) Hydroxyeicosatetraenoic acid; 15 lipoxygenase 1; Reactive oxygen species; Tight junction; Xanthine oxidase

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; ALLOPURINOL; ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; JUNCTION ADHESION MOLECULE A; JUNCTIONAL ADHESION MOLECULE; OCCLUDIN; REACTIVE OXYGEN METABOLITE; TYROSINE; UNCLASSIFIED DRUG; XANTHINE OXIDASE; 12-15-LIPOXYGENASE; 15-HYDROXY-5,8,11,13,17-EICOSAPENTAENOIC ACID; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; F11R PROTEIN, MOUSE; FAT INTAKE; ICOSAPENTAENOIC ACID;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LEUKOCYTE; LEUKOCYTE ADHERENCE; LIPID DIET; MONOCYTE; MOUSE; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TIGHT JUNCTION; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; ANIMAL; CAPILLARY PERMEABILITY; DRUG EFFECTS; ENZYMOLOGY; FAT INTAKE; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHARMACOLOGY; VASCULAR ENDOTHELIUM;

ANIMALS; AORTA; ARACHIDONATE 12-LIPOXYGENASE; ARACHIDONATE 15-LIPOXYGENASE; CAPILLARY PERMEABILITY; CELL ADHESION MOLECULES; DIETARY FATS; EICOSAPENTAENOIC ACID; ENDOTHELIUM, VASCULAR; MICE; MICE, KNOCKOUT; REACTIVE OXYGEN SPECIES; RECEPTORS, CELL SURFACE; TIGHT JUNCTIONS; XANTHINE OXIDASE;

EID: 84924603360     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M055566ERR     Document Type: Erratum

References (55)

1. Cines, D. B., E. S.Pollak, C. A.Buck, J.Loscalzo, G. A.Zimmerman, R. P.McEver, J. S.Pober, T. M.Wick, B. A.Konkle, B. S.Schwartz, et al . 1998 . Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood . 91 : 3527 - 3561 .
2. Pober, J. S., and W. C. Sessa . 2007 . Evolving functions of endothelial cells in infl ammation.Nat. Rev. Immunol.7 : 803-815 .
3. Bazzoni, G., and E. Dejana . 2004 . Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol. Rev. 84 : 869-901 .
4. Dejana, E., E. Tournier-Lasserve, and B. M. Weinstein . 2009 . The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev. Cell . 16 : 209-221 .
5. Goddard, L. M., and M. L. Iruela-Arispe . 2013 . Cellular and molecular regulation of vascular permeability. Thromb. Haemost. 109 : 407-415 .
6. Wautier, J. L., C. Zoukourian, O. Chappey, M. P. Wautier, P. J. Guillausseau, R. Cao, O. Hori, D. Stern, and A. M. Schmidt . 1996 . Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J. Clin. Invest. 97 : 238-243 .
7. Cai, H., and D. G. Harrison . 2000 . Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 87 : 840-844 .
8. Leopold, J. A., and J. Loscalzo . 2009 . Oxidative risk for atherothrombotic cardiovascular disease. Free Radic. Biol. Med. 47 : 1673-1706 .
9. Drummond, G. R., S. Selemidis, K. K. Griendling, and C. G. Sobey . 2011 . Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat. Rev. Drug Discov. 10 : 453-471 .
10. Gertzberg, N., P. Neumann, V. Rizzo, and A. Johnson . 2004 . NAD(P)H oxidase mediates the endothelial barrier dysfunction induced by TNF-alpha. Am. J. Physiol. Lung Cell. Mol. Physiol. 286 : L37-L48 .
11. Boueiz, A., and P. M. Hassoun . 2009 . Regulation of endothelial barrier function by reactive oxygen and nitrogen species. Microvasc. Res. 77 : 26-34 .
12. Meneshian, A., and G. B. Bulkley . 2002 . The physiology of endothelial xanthine oxidase: from urate catabolism to reperfusion injury to infl ammatory signal transduction. Microcirculation . 9 : 161-175 .
13. Ichida, K., Y. Amaya, K. Noda, S. Minoshima, T. Hosoya, O. Sakai, N. Shimizu, and T. Nishino . 1993 . Cloning of the cDNA encoding human xanthine dehydrogenase (oxidase): structural analysis of the protein and chromosomal location of the gene. Gene . 133 : 279-284 .
14. Wright, R. M., G. M. Vaitaitis, C. M. Wilson, T. B. Repine, L. S. Terada, and J. E. Repine . 1993 . cDNA cloning, characterization, and tissue-specifi c expression of human xanthine dehydrogenase/ xanthine oxidase. Proc. Natl. Acad. Sci. USA . 90 : 10690-10694 .
15. Harris, C. M., and V. Massey . 1997 . The reaction of reduced xanthine dehydrogenase with molecular oxygen. Reaction kinetics and measurement of superoxide radical. J. Biol. Chem. 272 : 8370-8379 .
16. Berry, C. E., and J. M. Hare . 2004 . Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J. Physiol. 555 : 589-606 .
17. Kushiyama, A., H. Okubo, H. Sakoda, T. Kikuchi, M. Fujishiro, H. Sato, S. Kushiyama, M. Iwashita, F. Nishimura, T. Fukushima, et al . 2012 . Xanthine oxidoreductase is involved in macrophage foam cell formation and atherosclerosis development. Arterioscler. Thromb. Vasc. Biol. 32 : 291-298 .
18. Butler, R., A. D. Morris, J. J. Belch, A. Hill, and A. D. Struthers . 2000 . Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension . 35 : 746-751 .
19. Guthikonda, S., C. Sinkey, T. Barenz, and W. G. Haynes . 2003 . Xanthine oxidase inhibition reverses endothelial dysfunction in heavy smokers. Circulation . 107 : 416-421 .
20. Kundumani-Sridharan, V., E. Dyukova, D. E. Hansen 3rd, and G. N. Rao . 2013 . 12/15-Lipoxygenase mediates high-fat diet-induced endothelial tight junction disruption and monocyte transmigration: a new role for 15(S)-hydroxyeicosatetraenoic acid in endothelial cell dysfunction. J. Biol. Chem. 288 : 15830-15842 .
21. Chattopadhyay, R., E. Dyukova, N. K. Singh, M. Ohba, J. A. Mobley, and G. N. Rao . 2014 . Vascular endothelial tight junctions and barrier function are disrupted by 15(S)-hydroxyeicosatetraenoic acid partly via protein kinase C epsilon-mediated zona occludens-1 phosphorylation at threonine 770/772. J. Biol. Chem. 289 : 3148-3163 .
22. Kotla, S., N. K. Singh, M. R. Heckle, G. J. Tigyi, and G. N. Rao . 2013 . The transcription factor CREB enhances interleukin-17A production and infl ammation in a mouse model of atherosclerosis. Sci. Signal. 6 : ra83 .
23. Webber, P. J., A. D.Smith, S.Sen, M. B.Renfrow, J. A.Mobley, and A. B.West . 2011 . Autophosphorylation in the leucine-rich repeat kinase 2 (LRRK2) GTPase domain modifi es kinase and GTPbinding activities. J. Mol. Biol. 412 : 94 - 110 .
24. Miles, A. A., and E. M. Miles . 1952 . Vascular reactions to histamine, histamine-liberator and leukotaxine in the skin of guinea-pigs.J. Physiol.118 : 228-257 .
25. Zhao, L., and C. D. Funk . 2004 . Lipoxygenase pathways in atherogenesis. Trends Cardiovasc. Med. 14 : 191-195 .
26. Yeh, M., N. M.Gharavi, J.Choi, X.Hsieh, E.Reed, K. P.Mouillesseaux, A. L.Cole, S. T.Reddy, and J. A.Berliner . 2004 . Oxidized phospholipids increase interleukin 8 (IL-8) synthesis by activation of the c-src/signal transducers and activators of transcription (STAT)3 pathway. J. Biol. Chem. 279 : 30175 - 30181 . 27 .
27. Buckbinder, L., D. T. Crawford, H. Qi, H. Z. Ke, L. M. Olson, K. R. Long, P. C. Bonnette, A. P. Baumann, J. E. Hambor, W. A. Grasser 3rd, et al . 2007 . Proline-rich tyrosine kinase 2 regulates osteoprogenitor cells and bone formation, and offers an anabolic treatment approach for osteoporosis. Proc. Natl. Acad. Sci. USA . 104 : 10619 - 10624
28. Chang, M. S., C. Schneider, R. L. Roberts, S. B. Shappell, F. R. Haselton, W. E. Boeglin, and A. R. Brash . 2005 . Detection and subcellular localization of two 15S-lipoxygenases in human cornea. Invest. Ophthalmol. Vis. Sci.46 : 849-856 .
29. Kühn, H., and V. B. O'Donnell . 2006 . Infl ammation and immune regulation by 12/15-lipoxygenases. Prog. Lipid Res. 45 : 334-356 .
30. Hatley, M. E., S. Srinivasan, K. B. Reilly, D. T. Bolick, and C. C. Hedrick . 2003 . Increased production of 12/15 lipoxygenase eicosanoids accelerates monocyte/endothelial interactions in diabetic db/db mice. J. Biol. Chem. 278 : 25369-25375 .
31. Brash, A. R. 1999 . Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate. J. Biol. Chem. 274 : 23679-23682 .
32. Fern á-ndez-Martín, L., B. Marcos-Ramiro, C. L. Bigarella, M. Graupera, R. J. Cain, N. Reglero-Real, A. Jimenez, E. Cernuda- Morollon, I. Correas, S. Cox, et al . 2012 . Crosstalk between reticular adherens junctions and platelet endothelial cell adhesion molecule-1 regulates endothelial barrier function. Arterioscler. Thromb. Vasc. Biol. 32 : e90 - e102 .
33. Dejana, E. 2004 . Endothelial cell-cell junctions: happy together. Nat. Rev. Mol. Cell Biol. 5 : 261-270 .
34. Itoh, M., A. Nagafuchi, S. Yonemura, T. Kitani-Yasuda, S. Tsukita, and S. Tsukita . 1993 . The 220-kD protein colocalizing with cadherins in non-epithelial cells is identical to ZO-1, a tight junction-associated protein in epithelial cells: cDNA cloning and immunoelectron microscopy. J. Cell Biol. 121 : 491-502 .
35. Capaldo, C. T., and I. G. Macara . 2007 . Depletion of E-cadherin disrupts establishment but not maintenance of cell junctions in Madin-Darby canine kidney epithelial cells. Mol. Biol. Cell . 18 : 189-200 .
36. Morita, K., H. Sasaki, M. Furuse, and S. Tsukita . 1999 . Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J. Cell Biol. 147 : 185-194 .
37. Itoh, M., M. Furuse, K. Morita, K. Kubota, M. Saitou, and S. Tsukita . 1999 . Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J. Cell Biol. 147 : 1351-1363 .
38. Matter, K., and M. S. Balda . 2003 . Signalling to and from tight junctions. Nat. Rev. Mol. Cell Biol. 4 : 225-236 .
39. Traweger, A., G. Wiggin, L. Taylor, S. A. Tate, P. Metalnikov, and T. Pawson . 2008 . Protein phosphatase 1 regulates the phosphorylation state of the polarity scaffold Par-3. Proc. Natl. Acad. Sci. USA . 105 : 10402-10407 .
40. Iden, S., S. Misselwitz, S. S. Peddibhotla, H. Tuncay, D. Rehder, V. Gerke, H. Robenek, A. Suzuki, and K. Ebnet . 2012 . aPKC phosphorylates JAM-A at Ser285 to promote cell contact maturation and tight junction formation. J. Cell Biol. 196 : 623-639 .
41. Van Itallie, C. M., A. J. Tietgens, K. LoGrande, A. Aponte, M. Gucek, and J. M. Anderson . 2012 . Phosphorylation of claudin-2 on serine 208 promotes membrane retention and reduces traffi cking to lysosomes. J. Cell Sci. 125 : 4902-4912 .
42. Raleigh, D. R., D. M. Boe, D. Yu, C. R. Weber, A. M. Marchiando, E. M. Bradford, Y. Wang, L. Wu, E. E. Schneeberger, L. Shen, et al . 2011 . Occludin S408 phosphorylation regulates tight junction protein interactions and barrier function. J. Cell Biol. 193 : 565-582 .
43. Engelhardt, S., A. J. Al-Ahmad, M. Gassmann, and O. O. Ogunshola . 2014 . Hypoxia selectively disrupts brain microvascular endothelial tight junction complexes through a hypoxia-inducible factor-1 (HIF-1) dependent mechanism. J. Cell. Physiol. 229 : 1096-1105 .
44. Dikic, I., G.Tokiwa, S.Lev, S. A.Courtneidge, and J.Schlessinger . 1996 . A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature . 383 : 547 - 550 . 45 .
45. Andreev, J., M. L. Galisteo, O. Kranenburg, S. K. Logan, E. S. Chiu, M. Okigaki, L. A. Cary, W. H. Moolenaar, and J. Schlessinger . 2001 . Src and Pyk2 mediate G-protein-coupled receptor activation of epidermal growth factor receptor (EGFR) but are not required for coupling to the mitogen-activated protein (MAP) kinase signaling cascade.J. Biol. Chem.276 : 20130-20135 .
46. Henriksson, P., M. Hamberg, and U. Diczfalusy . 1985 . Formation of 15-HETE as a major hydroxyeicosatetraenoic acid in the atherosclerotic vessel wall. Biochim. Biophys. Acta . 834 : 272-274 .
47. Simon, T. C., A. N. Makheja, and J. M. Bailey . 1989 . Formation of 15-hydroxyeicosatetraenoic acid (15-HETE) as the predominant eicosanoid in aortas from Watanabe Heritable Hyperlipidemic and cholesterol-fed rabbits. Atherosclerosis . 75 : 31-38 .
48. Bailey, J. M., A. N. Makheja, R. Lee, and T. H. Simon . 1995 . Systemic activation of 15-lipoxygenase in heart, lung, and vascular tissues by hypercholesterolemia: relationship to lipoprotein oxidation and atherogenesis. Atherosclerosis . 113 : 247-258 .
49. Ylä-Herttuala, S., J. Luoma, H. Viita, T. Hiltunen, T. Sisto, and T. Nikkari . 1995 . Transfer of 15-lipoxygenase gene into rabbit iliac arteries results in the appearance of oxidation-specifi c lipid-protein adducts characteristic of oxidized low density lipoprotein. J. Clin. Invest. 95 : 2692-2698 .
50. Sendobry, S. M., J. A.Cornicelli, K.Welch, T.Bocan, B.Tait, B. K.Trivedi, N.Colbry, R. D.Dyer, S. J.Feinmark, and A.Daugherty . 1997 . Attenuation of diet-induced atherosclerosis in rabbits with a highly selective 15-lipoxygenase inhibitor lacking signifi cant antioxidant properties. Br. J. Pharmacol. 120 : 1199 - 1206
51. Cyrus, T., J. L. Witztum, D. J. Rader, R. Tangirala, S. Fazio, M. F. Linton, and C. D. Funk . 1999 . Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-defi cient mice.J. Clin. Invest.103 : 1597-1604 .
52. Ley, K., C. Laudanna, M. I. Cybulsky, and S. Nourshargh . 2007 . Getting to the site of infl ammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7 : 678-689 .
53. Bolick, D. T., A. W.Orr, A.Whetzel, S.Srinivasan, M. E.Hatley, M. A.Schwartz, and C. C.Hedrick . 2005 . 12/15-lipoxygenase regulates intercellular adhesion molecule-1 expression and monocyte adhesion to endothelium through activation of RhoA and nuclear factor-kappaB. Arterioscler. Thromb. Vasc. Biol. 25 : 2301 - 2307 . 54
54. Rao, R. M., L. Yang, G. Garcia-Cardena, and F. W. Luscinskas . 2007 . Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall.Circ. Res.101 : 234-247 .
55. Zhu, H., Y. Takahashi, W. Xu, H. Kawajiri, T. Murakami, M. Yamamoto, S. Iseki, T. Iwasaki, H. Hattori, and T. Yoshimoto . 2003 . Low density lipoprotein receptor-related protein-mediated membrane translocation of 12/15-lipoxygenase is required for oxidation of low density lipoprotein by macrophages. J. Biol. Chem. 278 : 13350-13355 .